A genetic contribution to susceptibility is well established in multiple sclerosis (MS) and 57 associated genetic loci have been identified. We have undertaken a meta-analysis of familial risk studies with the aims of providing definitive figures for risks to relatives, performing a segregation analysis and estimating the proportion of the overall genetic risk that currently identified genes represent. We have used standard methods of meta-analysis combined with novel approaches to age adjustment to provide directly comparable estimates of lifetime risk. The overall recurrence risk for monozygotic twins was 18.2% and for siblings 2.7%. The recurrence risk for dizygotic twins was significantly higher than for siblings. The overall estimate of sibling relative risk (λS) was 16.8. Risks for older relatives (parents, siblings, aunts, uncles and cousins) show a latitudinal gradient, in line with population risk. No latitudinal gradient for λS was seen. Segregation analysis supports a multiplicative model of one locus of moderate effect with many loci of small effect. The estimated contribution of the 57 known MS loci is 18–24% of λS. This meta-analysis supports the notion of MS being in part the result of multiple genetic susceptibility factors and environmental factors.

1.
Compston A, Coles A: Multiple sclerosis. Lancet 2008;372:1502–1517.
2.
Hawkes CH: Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 2007;13:610–615.
3.
Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV: An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 2010;5:e12496.
4.
Islam T, Gauderman WJ, Cozen W, Mack TM: Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins. Neurology 2007;69:381–388.
5.
Munger KL, Zhang SM, O’Reilly E, Hernan MA, Olek MJ, Willett WC, Ascherio A: Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60–65.
6.
Sadovnick AD, Baird PA: The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology 1988;38:990–991.
7.
Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, Grey T, et al: A population-based study of multiple sclerosis in twins. N Engl J Med 1986;315:1638–1642.
8.
Ebers GC, Sadovnick AD, Risch NJ: A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995;377:150–151.
9.
Sadovnick AD, Ebers GC, Dyment DA, Risch NJ: Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996;347:1728–1730.
10.
Robertson NP, O’Riordanm JI, Chataway J, Kingsley DP, Miller DH, Clayton D, Compston DA: Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997;349:1587–1590.
11.
Jersild C, Dupont B, Fog T, Platz PJ, Svejgaard A: Histocompatibility determinants in multiple sclerosis. Transplant Rev 1975;22:148–163.
12.
GAMES, Transatlantic Multiple Sclerosis Genetics Cooperative: A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 2003;143:39–46.
13.
Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene): Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009;41:824–828.
14.
De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, Pericak-Vance MA, Haines JL, Gibson RA, Naeglin Y, Uitdehaag B, Matthews PM, Kappos L, Polman C, McArdle WL, Strachan DP, Evans D, Cross AH, Daly MJ, Compston A, Sawcer SJ, Weiner HL, Hauser SL, Hafler DA, Oksenberg JR: Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009;41:776–782.
15.
Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL: Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357:851–862.
16.
Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D’Alfonso S, Blackburn H, Boneschi FM, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D’Hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppa V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Ruckert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sorensen PS, Sondergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvanen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A: Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214–219.
17.
Hemminki K, Lorenzo Bermejo J, Forsti A: The balance between heritable and environmental aetiology of human disease. Nat Rev Genet 2006;7:958–965.
18.
Risch N: Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222–228.
19.
Risch N: Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987;40:1–14.
20.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–127.
21.
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O’Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 2005;58:840–846.
22.
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–231.
23.
Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, Mcdowell F, Nagler B, Sibley WA, Tourtellotte WW, Willmon TL: Problems of experimental trials of therapy in multiple sclerosis; report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 1965;122:552–568.
24.
Smith SM, Penrose LS: Monozygotic and dizygotic twin diagnosis. Ann Hum Genet 1955;19:273–289.
25.
Sutton HE, Clark PJ, Schull WJ: The use of multi-allele genetic characters in the diagnosis of twin zygosity. Am J Hum Genet 1955;7:180–188.
26.
Bharucha NE, Bharucha EP, Wadia NH, Singhal BS, Bharucha AE, Bhise AV, Kurtzke JF, Schoenberg BS: Prevalence of multiple sclerosis in the Parsis of Bombay. Neurology 1988;38:727–729.
27.
Risch N: Estimating morbidity risks in relatives: the effect of reduced fertility. Behav Genet 1983;13:441–451.
28.
Risch N: Estimating morbidity risks with variable age of onset: review of methods and a maximum likelihood approach. Biometrics 1983;39:929–939.
29.
Grubbs FE: Sample criteria for testing outlying observations. Ann Math Stat 1950;21:27–58.
30.
Smith C: Concordance in twins: methods and interpretation. Am J Hum Genet 1974;26:454–466.
31.
Davie AM: The ‘singles’ method for segregation analysis under incomplete ascertainment. Ann Hum Genet 1979;42:507–512.
32.
RevMan v5.0, Review Manager (RevMan). Copenhagen, Nordic Cochrane Centre, Cochrane Collaboration, 2008.
33.
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 2003;327:557–560.
34.
Sterne JA, Egger M: Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001;54:1046–1055.
35.
Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000;405:847–856.
36.
Falconer DS: The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet 1965;29:51–76.
37.
Columbia, Socioeconomic Data and Applications Centre, 2000. http://sedac.ciesin.columbia.edu/gpw/global.jsp.
38.
Kumler MP, Goodchild MF: The population centre of Canada – just north of Toronto; in Janelle DG (ed): Geographical Snapshots of North America. New York, Guilford, 1992, pp 275–279.
39.
Australian Institute of Health and Welfare, National Heart Foundation of Australia: Heart, Stroke and Vascular Diseases. Australian Facts. Canberra, Australian Institute of Health and Welfare & National Heart Foundation of Australia, 1999.
40.
Carton H, Vlietinck R, Debruyne J, De Keyser J, D’Hooghe MB, Loos R, Medaer R, Truyen L, Yee IM, Sadovnick AD: Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry 1997;62:329–333.
41.
Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. French Research Group on Multiple Sclerosis. Ann Neurol 1992;32:724–727.
42.
Grasso MG, Frontali M, Bernardi S, Pantano P, Fieschi C: Multifactorial inheritance and recurrence risks of multiple sclerosis in Italian patients. Neuroepidemiology 1989;8:300–307.
43.
Hansen T, Skytthe A, Stenager E, Petersen HC, Bronnum-Hansen H, Kyvik KO: Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Mult Scler 2005;11:504–510.
44.
Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, Mack TM: Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol 2006;60:56–64.
45.
Koch-Henriksen N: An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors. Acta Neurol Scand Suppl 1989;124:1–123.
46.
Kuusisto H, Kaprio J, Kinnunen E, Luukkaala T, Koskenvuo M, Elovaara I: Concordance and heritability of multiple sclerosis in Finland: study on a nationwide series of twins. Eur J Neurol 2008;15:1106–1110.
47.
Marrosu MG, Lai M, Cocco E, Loi V, Spinicci G, Pischedda MP, Massole S, Marrosu G, Contu P: Genetic factors and the founder effect explain familial MS in Sardinia. Neurology 2002;58:283–288.
48.
Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA: The British Isles survey of multiple sclerosis in twins. Neurology 1994;44:11–15.
49.
O’Gorman C, Freeman S, Taylor BV, Butzkueven H, Broadley SA: Familial recurrence risks for multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry 2011;82:1351–1354.
50.
Prokopenko I, Montomoli C, Ferrai R, Musu L, Piras ML, Ticca A, Murgia BS, Bernardinelli L: Risk for relatives of patients with multiple sclerosis in central Sardinia, Italy. Neuroepidemiology 2003;22:290–296.
51.
Ristori G, Cannoni S, Stazi MA, Vanacore N, Cotichini R, Alfo M, Pugliatti M, Sotgiu S, Solaro C, Bomprezzi R, Di Giovanni S, Figa Talamanca L, Nistico L, Fagnani C, Neale MC, Cascino I, Giorgi G, Battaglia MA, Buttinelli C, Tosi R, Salvetti M: Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study. Ann Neurol 2006;59:27–34.
52.
Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA: Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996;119(Pt 2):449–455.
53.
Sadovnick AD, Baird PA, Ward RH: Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988;29:533–541.
54.
Sazdovitch V, Verdier-Taillefer MH, Heinzlef O, Alamowitch S, Roullet E: Familial multiple sclerosis: study of 357 consecutive patients (in French). Rev Neurol (Paris) 2000;156:638–640.
55.
Uitdehaag BM, Polman CH, Valk J, Koetsier JC, Lucas CJ: Magnetic resonance imaging studies in multiple sclerosis twins. J Neurol Neurosurg Psychiatry 1989;52:1417–1419.
56.
Wikström J, Kinnunen E, Porras J: The age-specific prevalence ratio of familial multiple sclerosis. J Neuroepidemiol 1984;3:74–81.
57.
Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC: Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003;100:12877–12882.
58.
Simpson S Jr, Pittas F, van der Mei I, Blizzard L, Ponsonby AL, Taylor B: Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009. J Neurol Neurosurg Psychiatry 2011;82:180–187.
59.
Tong S: Dizygotic to monozygotic twinning ratio at the Royal Women’s Hospital, Melbourne 1947–1997, compared with Australian national twinning incidence. Twin Res 2000;3:12–16.
60.
Bulmer MG: The Biology of Twinning in Man. Oxford, Clarendon Press, 1970.
61.
Hoekstra C, Zhao ZZ, Lambalk CB, Willemsen G, Martin NG, Boomsma DI, Montgomery GW: Dizygotic twinning. Hum Reprod Update 2008;14:37–47.
62.
Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch N: Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004;363:1773–1774.
63.
Dyment DA, Yee IM, Ebers GC, Sadovnick AD: Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006;77:258–259.
64.
Hupperts R, Broadley S, Mander A, Clayton D, Compston DA, Robertson NP: Patterns of disease in concordant parent-child pairs with multiple sclerosis. Neurology 2001;57:290–295.
65.
Sadovnick AD, Yee IM, Ebers GC, Risch NJ: Effect of age at onset and parental disease status on sibling risks for MS. Neurology 1998;50:719–723.
66.
Ebers GC, Yee IM, Sadovnick AD, Duquette P: Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Canadian Collaborative Study Group. Ann Neurol 2000;48:927–931.
67.
Maghzi AH, Etemadifar M, Shaygannejad V, Saadatnia M, Salehi M, Hassanzadeh A: Conjugal multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 2007;13:673–675.
68.
Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, updated March 2011. www. cochrane-handbook.org.
69.
Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL: The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008;9:516–526.
70.
Wang JH, Pappas D, De Jager PL, Pelletier D, de Bakker PI, Kappos L, Polman CH, Chibnik LB, Hafler DA, Matthews PM, Hauser SL, Baranzini SE, Oksenberg JR: Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med 2011;3:3.
71.
Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, Roxburgh R, Coraddu F, Smith S, Compston DA: HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;72:184–187.
72.
Ascherio A, Munger KL, Simon KC: Vitamin D and multiple sclerosis. Lancet Neurol 2010;9:599–612.
73.
Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV, Kilpatrick TJ, Dwyer T, Coulthard A, Chapman C, van der Mei I, Williams D, McMichael AJ: Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011;76:540–548.
74.
Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC: A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010;20:1352–1360.
75.
Hawkes CH, Macgregor AJ: Twin studies and the heritability of MS: a conclusion. Mult Scler 2009;15:661–667.
76.
Risch N: The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001;10:733–741.
77.
Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC: Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330:120.
78.
Ramagopalan SV, Dyment DA, Ebers GC: Autoimmune disease in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark. Mult Scler 2008;14:1288–1289, author reply 1290–1291.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.